Skip to main content

Table 6 The comparison of clinicopathological characteristics between EBV positive and negative RCC patients (n = 122)

From: Epstein–Barr virus infection is associated with the nuclear factor-kappa B p65 signaling pathway in renal cell carcinoma

Variable

All patients

EBV positive patients

N (%)

EBV negative patients

N (%)

p value

Total

122 (100)

33 (27.0)

89 (72.9)

 

Gender

 Male

70 (57.4)

17 (51.1)

53 (59.5)

0.425

 Female

52 (42.6)

16 (48.4)

36 (40.4)

 

Age

 ≥ 54

58 (47.5)

17 (51.1)

41 (46)

0.592

 ˂ 54

64 (52.5)

16 (48.4)

48 (53.9)

 

Tumor location

 Right

67 (54.9)

19 (57.5)

48 (53.9)

0.719

 Left

55 (45.1)

14 (42.4)

41 (46)

 

Tumor grade

 G1

55 (45.1)

13 (39.3)

42 (47.1)

0.893

 G2

44 (36.1)

13 (39.3)

31 (34.8)

 

 G3

20 (16.4)

6 (18.1)

14 (15.7)

 

 G4

3 (2.4)

1 (3)

2 (2.2)

 

pT category

 pT1

58 (47.5)

16 (48.4)

42 (47.1)

0.725

 pT2

43 (35.2)

13 (39.3)

30 (33.7)

 

 pT3

19 (15.6)

4 (12.1)

15 (16.8)

 

 pT4

2 (1.6)

0

2 (2.2)

 

Histologic types

 Conventional

77 (63.1)

23 (69.7)

54 (60.6)

0.357

 Papillary

26 (21.3)

6 (18.1)

20 (22.4)

 

 Chromophobe

14 (11.5)

2 (6)

12 (13.4)

 

 Collecting duct

1 (0.8)

1 (3)

0

 

 Unclassified

4 (3.3)

1 (3)

3 (3.3)

 
  1. pT primary tumor